Genfit Stock

Genfit Forward P/E

The Forward P/E Ratio of Genfit (GNFT.PA) as of Aug 15, 2026 is 291.01. In the previous year, Forward P/E Ratio was -15.18 — a change of -2,017.32% (higher).

Forward P/E

291.01

YoY

-2,017.32%

Last updated:

Forward P/E Ratio of Genfit is 2026 291.01 . Forward P/E Ratio of Genfit was 2025 -15.18 . It decreases by -2,017.32% higher compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

Forward P/E Ratio of Genfit is 291.01 in 2026.

Forward P/E Ratio of Genfit changed from -15.18 to 291.01, representing a -2,017.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Genfit since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Genfit with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genfit

All Key Metrics — Genfit